Pasithea Therapeutics Cor...
(KTTAW)
undefined
undefined%
At close: undefined
0.00
-100.00%
After-hours Dec 31, 1969, 07:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 | FY21 | FY20 |
Net Income | -15.51M | -13.94M | -2.17M | -40.98K |
Depreciation & Amortization | 648.45K | 32.37K | 1.38K | - |
Stock-Based Compensation | 592.27K | 835.06K | 471.25K | - |
Other Working Capital | 1.57M | -831.78M | -329.44K | 2.29K |
Other Non-Cash Items | -121.29K | -1.07M | 750.00K | 9.90K |
Deferred Income Tax | - | - | -2.33M | - |
Change in Working Capital | 1.57M | -138.44K | 111.23K | 2.29K |
Operating Cash Flow | -12.81M | -14.56M | -3.17M | -38.69K |
Capital Expenditures | -34.3 | -2.14M | -21.50K | - |
Acquisitions | - | 77.06K | - | - |
Purchase of Investments | - | - | - | - |
Sales Maturities Of Investments | - | - | - | - |
Other Investing Acitivies | 433.31K | -626.90K | - | - |
Investing Cash Flow | 399.01K | -2.06M | -21.50K | - |
Debt Repayment | - | - | - | - |
Common Stock Repurchased | -3.73M | -3.21M | - | - |
Dividend Paid | - | - | - | - |
Other Financial Acitivies | - | -3.21K | 5.69M | 282.34K |
Financial Cash Flow | -3.73M | -3.21M | 55.93M | 282.34K |
Net Cash Flow | -16.76K | -19.82M | 52.72M | 243.65K |
Free Cash Flow | -13.46M | -16.70M | -3.20M | -38.69K |